Interaction between braf inhibitor PLX-4720 and CDKS inhibitors can sensitize melanoma cells with braf V600E mutation

Tharcísio Citrângulo Tortelli Junior Roger Chammas; Srikumar Chellappan; Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences (18. 2013 São Paulo); Symposium on Drug Design and Development for Neglected Diseases (3. 2013 São Paulo); Workshop on Melanoma, Skin and Photoprotection (5. 2013 São Paulo)

Brazilian Journal of Pharmaceutical Sciences São Paulo v. 49, suppl. 3, p. 94, res. MEL015, 2013

São Paulo 2013

Localização: FM - Fac. Medicina    (BCBIB ) e outros locais(Acessar)